Scholars Central

Conference abstractPublished 21 Nov 2016

The prognostic utility of pre-treatment 18F-FDG-PET for salvage re-irradiation in head and neck cancer patients

Authors: Kateryna Musaiev

Clinical Hospital Feofaniya, Ukraine

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Statistical image features of tumor metabolism from pretreatment 18F-FDG-PET/CT scans were studied for their potential to predict clinical outcome of salvage re-irradiation with intensity modulated radiotherapy (IMRT) for recurrent squamous cell carcinoma of head and neck (HNSCC). Materials & Methods: Pretreatment PET/CT scans and after treatment PET/CT scans of patients who underwent IMRT re-irradiation for recurrent HNSCC, were retrospectively evaluated. Metabolic response was assessed using PET response criteria for solid tumors (PERCIST). Multiple statistical image features related to the standard uptake value (SUV) were computed: Metabolic tumor volume, maximum SUV, mean SUV and total lesion glycolysis (TLG). The correlation between the image features and local control and overall survival was calculated. Results: Complete tumor metabolic response (CMR) was achieved in 5 patients (45.5%). Six (6) patients failed to achieve CMR: Progressive metabolic disease was in 4 patients (36.4%); stable metabolic disease in 1 patient (9.1%); and 1 patient had partial metabolic response (9.1%). The median follow-up time was 18.2 months. Out of the calculated image features, only pre-treatment tumor TLG (individual tumor volume multiplied by its mean SUV) correlated with tumor metabolic response in the early PET/CT follow-up. Also dividing the patient population based on the median tumor TLG showed a split of the Kaplan-Meier survival curves. Conclusions: The tumor TLG of pre-treatment PET/CT scans has important information on the failure risk to achieve CMR in recurrent HNSCC patients. It is necessary to obtain additional patients data to validate these results.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Kateryna Musaiev”